Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Branded Generics Market: By Disease Indication, By Route of Administration, By Distribution Channel, and Region Forecast 2019-2030
Branded Generics market size was valued at US$ 242.4 billion in 2023 and is poised to grow at a CAGR of 5.9% from 2024 to 2030. The global market provides a detailed overview of the market and which can be segmented by disease, route of administration, distribution channel, and region. By disease, the market has been segmented into cardiovascular diseases, diabetes, cancer, neurological disorders, gastrointestinal diseases, dermatology diseases, and others. By disease, the cardiovascular disease segment accounts for increasing sales of branded generics in the global market.
According to World Health Organization (WHO), around 17.9 million people die every year from cardiovascular diseases (CVDs) across the world. Correspondingly, 1.13 billion people worldwide have hypertension. This leads to the adoption of branded generics such as anti-hypertensive drugs, which ultimately expands market. By route of administration, the market has been segmented into oral, parenteral, topical, and others. By route of administration, the oral segment leads the market with a significant share. The segments growth can be attributed to the convenience factor associated with oral administration. Oral medications are easy to administer and patient compliance with oral medication is more than other routes of administration.
Furthermore, tablets and capsules are being made more palatable using sweeteners and colored coatings. Based on the distribution channel, the segment has been segregated into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Online Pharmacies are expected to have a considerable growth rate owing to the emergence of e-commerce, and manufacturers are forging alliances with online and retail pharmacies. An unprecedented pandemic of COVID-19 regularised branded generics shopping via online pharmacies. Patients find it easy and timesaving to get their medication from online pharmacies directly. As a result, online pharmacies are projected to gain traction through 2022 and beyond. By region, the North America market is expected to witness the highest market share during the forecast period owing to the well-established healthcare facilities and increasing prevalence of chronic diseases across the region, such as cardiovascular diseases, diabetes, Alzheimer's diseases, and Parkinson's diseases boosting the demand of market.
Study Period
2024-2030Base Year
2023CAGR
5.9%Largest Market
EuropeFastest Growing Market
Asia Pacific
Global market is primarily driven by a significant increase in cardiometabolic risk factors among a large proportion of people. The increasing prevalence of cancer cases is also playing an important role in the growth of the Branded Generics Market. However, a major factor, which is anticipated to hamper the growth of the market during the forecast period, is the misapplication of risk evaluation and mitigation strategies (REMS) to market entry.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 242.4 billion |
Market CAGR |
5.9% |
By Indication |
|
By Route Administration |
|
By Distribution Channel |
|
By Region |
|
Download Free Sample Report
The global branded generics market size was valued at US$ 242.4 billion in 2023 and is set to grow at a CAGR of 5.9% during the forecast period 2024-2030.
The introduction of new branded generics, encouraging the usage of branded generics by healthcare suppliers and professionals, and a two-tiered strategy are major key trends pushing the market.
The U.S., China, India, Russia, and Brazil are the key manufacturers of branded generics.
1. Executive Summary |
2. Global Branded Generics Market Introduction |
2.1.Global Branded Generics Market - Taxonomy |
2.2.Global Branded Generics Market - Definitions |
2.2.1.Indication |
2.2.2.Route of Administration |
2.2.3.Distribution Channel |
2.2.4.Region |
3. Global Branded Generics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Branded Generics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Branded Generics Market By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Cardiovascular |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Diabetes |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Cancer |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Neurological Disorders |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Gastrointestinal Diseases |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Dermatology Diseases |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Others |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
6. Global Branded Generics Market By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Oral |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Parenteral |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Topical |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Branded Generics Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital Pharmacies |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacies |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Drug Stores |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Online Pharmacies |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Branded Generics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Branded Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Cardiovascular |
9.1.2.Diabetes |
9.1.3.Cancer |
9.1.4.Neurological Disorders |
9.1.5.Gastrointestinal Diseases |
9.1.6.Dermatology Diseases |
9.1.7.Others |
9.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Oral |
9.2.2.Parenteral |
9.2.3.Topical |
9.2.4.Others |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacies |
9.3.2.Retail Pharmacies |
9.3.3.Drug Stores |
9.3.4.Online Pharmacies |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Branded Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cardiovascular |
10.1.2.Diabetes |
10.1.3.Cancer |
10.1.4.Neurological Disorders |
10.1.5.Gastrointestinal Diseases |
10.1.6.Dermatology Diseases |
10.1.7.Others |
10.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Oral |
10.2.2.Parenteral |
10.2.3.Topical |
10.2.4.Others |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacies |
10.3.2.Retail Pharmacies |
10.3.3.Drug Stores |
10.3.4.Online Pharmacies |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11. Asia Pacific (APAC) Branded Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cardiovascular |
11.1.2.Diabetes |
11.1.3.Cancer |
11.1.4.Neurological Disorders |
11.1.5.Gastrointestinal Diseases |
11.1.6.Dermatology Diseases |
11.1.7.Others |
11.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Oral |
11.2.2.Parenteral |
11.2.3.Topical |
11.2.4.Others |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacies |
11.3.2.Retail Pharmacies |
11.3.3.Drug Stores |
11.3.4.Online Pharmacies |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Branded Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cardiovascular |
12.1.2.Diabetes |
12.1.3.Cancer |
12.1.4.Neurological Disorders |
12.1.5.Gastrointestinal Diseases |
12.1.6.Dermatology Diseases |
12.1.7.Others |
12.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Oral |
12.2.2.Parenteral |
12.2.3.Topical |
12.2.4.Others |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacies |
12.3.2.Retail Pharmacies |
12.3.3.Drug Stores |
12.3.4.Online Pharmacies |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Branded Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Cardiovascular |
13.1.2.Diabetes |
13.1.3.Cancer |
13.1.4.Neurological Disorders |
13.1.5.Gastrointestinal Diseases |
13.1.6.Dermatology Diseases |
13.1.7.Others |
13.2. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Oral |
13.2.2.Parenteral |
13.2.3.Topical |
13.2.4.Others |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacies |
13.3.2.Retail Pharmacies |
13.3.3.Drug Stores |
13.3.4.Online Pharmacies |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Abbott Laboratories (U.S.) |
14.2.2.Apotex Inc. (Canada) |
14.2.3.AstraZeneca (U.K) |
14.2.4.Reddys Laboratories Ltd. (India) |
14.2.5.GlaxoSmithKline plc (U.K) |
14.2.6.Mylan N.V. (U.S.) |
14.2.7.Pfizer Inc. (U.S) |
14.2.8.Novartis AG (Switzerland) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players